Location: Home
  • search
  • go
  • Relate News
  • 9/15/2025BMS to Divest Majority Stake in Historic China JV to Hillhouse Capital
  • 9/15/2025FibroGen Settles SEC Allegations Over Roxadustat Data Manipulation
  • 9/15/2025Several Chinese Biotech Firms Added to U.S. Entity List Amid Security ...
  • 9/15/2025CSPC Receives Approval for Parkinson's Disease Drug Trial in China
  • 9/15/2025Chinese Biotech Startups Face Mixed Earnings amid Ambitious Global Exp...
  • 9/15/2025Merger Control in China's Healthcare Industry: Insights into Antitrust...
  • 9/13/2025NHSA Issues the Regulations on DRG/DIP Healthcare Security Payment Mec...
  • 9/13/2025CDE Releases 96th Batch of Reference Formulations for Generic Drug Eva...
  • 9/13/2025Denovo's Publishes Landmark Trial in Precision Psychiatry in JAMA
  • 9/13/2025CDE Releases First Technical Guidelines for GLP-1 Drugs
  • 9/13/2025CDE Introduces New Risk Management Guidelines for Innovative Drugs
  • 9/13/2025CDE Releases New, Comprehensive Guidelines for Innovative Drug Trial A...
  • 9/13/2025CDE Seeks Public Opinions on New HIV/AIDS Drug Guidelines
  • 9/13/2025Nanjing's Triastek Builds World's Largest 3D-Printed Pharma Plant
  • 9/13/2025China to Incorporate HPV Vaccines into National Immunization Program
  • 9/13/2025Bayer Expands China Presence with New Innovation Platform and Biotech ...
  • 9/12/2025U.S. House Passes Bill That Could Sever Much of U.S.-China Academic Re...
  • 9/12/2025CDE Solicits Comments on Draft Guidance for Insomnia Drug Clinical Tri...
  • 9/12/2025CDE Seeks Feedback on Draft Guidance for Depression Drug Clinical Tria...
  • 9/12/2025CDE Solicits Input on Draft Guidance for Chronic Rhinosinusitis with N...
  • 9/12/2025CDE Seeks Feedback on Draft Guidance for Post-Approval Changes in Biol...
  • 9/12/2025China Approves FirboX's Fibroblast-Based Therapy for Clinical Trials
  • 9/12/2025China NMPA Drastically Shortens Drug Trial Review Times with New Polic...
  • 9/12/2025The Rise of US-China Biotech Partnerships: Opportunities and Emerging ...
  • 9/11/2025Chinese Biotechs Face Rising Hurdles in Advanced Therapies
  • 9/11/2025HKU-Med, GBAICTI and GSK Join Forces to Boost Real-World Clinical Rese...
  • 9/11/2025IDEAYA's IDE849 Shows Strong Results in Phase I Trial
  • 9/11/2025Henlius' HLX43 Shows Promising Results in Phase I Trial
  • 9/11/2025Novartis Gains Expanded Approval for Tabrecta in China
  • 9/11/2025RabPharma Raises Oversubscribed Series A++ to Push Ahead with RAB001d ...
  • Page:10/799 Total number of articles:23944: [First][<<] [8] [9] [10] [11] [12] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group